Back to search

Article

Constructing Immune Related Prognosis Score Based on Signatures to Predict the Benefit of Immunotherapy in Colorectal Cancer

2022-07-06

Abstract excerpt

Since FDA approved immune checkpoint inhibitors for the treatment of colorectal cancer in 2017, there have been significant differences in the response of colorectal cancer patients to immune checkpoint inhibitors. In order to achieve better clinical benefits in patients with colorectal cancer in immunotherapy, we urgently need to find a biomarker to evaluate whether colorectal cancer patients respond to immunothe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
06e31c8c-970a-5a68-ad74-51a9efcc97da
DOI
10.21203/rs.3.rs-1557469/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Constructing Immune Related Prognosis Score Based on Signatures to Predict the Benefit of Immunotherapy in Colorectal CancerDOI 10.21203/rs.3.rs-1557469/v2
Select a neighboring publication to make it the new centre.